3 ms·
EpiPen was literally granted market exclusivity by the FDA, there was a government enforced monopoly on the particular mechanism, one which was granted on what,
by maxerickson 8y ago
EpiPen was literally granted market exclusivity by the FDA, there was a government enforced monopoly on the particular mechanism, one which was granted on what, as far as I can tell, was a superficial improvement to the safety cap.
Mylan continues to try to restore their exclusive rights.
https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=019430&Appl_type=N https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.c...
- dfsegoat 8y agoI think you are misunderstanding "Market Exclusivity" vs. monopoly: Yes the EpiPen mechanism is patented, and people cannot knock it off directly - this is not a monopoly, because competitors have been allowed to create new designs for a long time. [1] The fact that Auvi-Q, TwinJect and many other Epi-autoinjectors are allowed on the market as New Drug Applications (Non-generic) shows us that the FDA has allowed healthy competition from other Autoinjector designs -- they simply have not been as effective, safe or simple to use, leaving EpiPen as the standard. 1- https://www.fda.gov/drugs/developmentapprovalprocess/ucm079031.htm#What_is_the_difference_between_patents_a https://www.fda.gov/drugs/developmentapprovalprocess/ucm0790...
- maxerickson 8y agoYeah, thanks for telling me I misunderstand it. It's not an economic monopoly, but (at least in the case of the EpiPen) it's bad regulation with similar impact.